Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1

Genes Chromosomes and Cancer

Volumn 36, Issue 4, 2003, Pages 340-352

  Jonson, Tord ^a   Heidenblad, Markus ^a   Håkansson, Petra ^a   Gorunova, Ludmila ^a   Johansson, Bertil ^a   Fioretos, Thoas ^a   Höglund, Mattias ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; FUNCTIONAL GROUP; SMAD4 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN GENETICS; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR CELL LINE;

CLUSTER ANALYSIS; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, NEOPLASM; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; RNA, NEOPLASM; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 0037376734     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10179     Document Type: Article

References (52)

1. Axmann A, Seidel D, Reimann T, Hempel U, Wenzel K-W. 1998. Transforming growth factor-beta1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism. Biochem Biophys Res Commun 249:456-460.
2. Baldwin RL, Friess H, Yokoyama M, Lopez ME, Kobrin MS, Büchler MW, Korc M. 1996. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer 67:283-288.
3. Böttinger EP, Jakubczak JL, Roberts ISD, Mumy M, Hemmati P, Bagnall K, Merlino G, Wakefield LM. 1997. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. EMBO J 16:2621-2633.
4. Caulín C, Scholl FG, Frontelo P, Gamallo C, Quintanilla M. 1995. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-beta 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ 6:1027-1035.
5. Chang L, Karin M. 2001. Mammalian MAP kinase signalling cascades. Nature 410:37-40.
6. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ. 1996. TGFB1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542.
7. Dalal BI, Keown PA, Greenberg AH. 1993. immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am J Pathol 143:381-389.
8. Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Giordano A, Khalili K. 1999. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1. Oncogene 18:6398-6402.
9. de Caestecker MP, Piek E, Roberts AB. 2000. Role of transforming growth factor-beta signaling in cancer. J Natl Cancer Inst 92:1388-1402.
10. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH. 1987. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712.
11. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
12. Ellenrieder V, Hendler SF, Ruhland C, Boeck W, Adler G, Gress TM. 2001. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int J Cancer 93:204-211.
13. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM. 1993. TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020.
14. Friess H, Yamanaka Y, Büchler M, Ebert M, Beger HG, Gold LI, Korc M. 1993. Enhanced expression of transforming growth factor-beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 105:1846-1856.
15. Geng MM, Ellenrieder V, Wallrapp C, Müller-Pillasch F, Sommer G, Adler G, Gress TM. 1999. Use of representational difference analysis to study the effect of TGFB on the expression profile of a pancreatic cancer cell line. Genes Chromosomes Cancer 26:70-79.
16. Gorunova L, Höglund M, Andrén-Sandberg Å, Dawiskiba S, Jin Y, Mitelman F, Johansson B. 1998. Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 23:81-99.
17. Griswold-Prenner I, Kamibayashi C, Maruoka EM, Mumby MC, Derynck R. 1998. Physical and functional interactions between type I transforming growth factor beta receptors and Balfa, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol 18:6595-6604.
18. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1995. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55:4670-4675.
19. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
20. Halstead J, Kemp K, Ignotz RA. 1995. Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth factor-beta signaling. J Biol Chem 270:13600-13603.
21. Hartsough MT, Frey RS, Zipfel PA, Buard A, Cook SJ, McCormick F, Mulder KM. 1996. Altered transforming growth factor beta signaling in epithelial cells when Ras activation is blocked. J Biol Chem 271:22368-22375.
22. Hocevar BA, Brown TL, Howe PH. 1999. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18:1345-1356.
23. Ito N, Kawata S, Tamura S, Takaischi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S. 1991. Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in hepatocellular carcinoma. Cancer Res 51:4080-4083.
24. Jackson BA, Goldstein RH, Roy R, Cozzani M, Taylor L, Polgar P. 1993. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun 197:1465-1474.
25. Johansson N, Westermarck J, Leppä S, Häkkinen L, Koivisto L, López-Otín C, Peltonen J, Heino J, Kähäri V-M. 1997. Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ 8:243-250.
26. Jonson T, Gorunova L, Dawiskiba S, Andrén-Sandberg A, Stenman G, ten Dijke P, Johansson B, Höglund M. 1999. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer. Genes Chromosomes Cancer 24:62-71.
27. Jonson T, Albrechtsson E, Axelson J, Heidenblad M, Gorunova L, Johansson B, Höglund M. 2001. Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas. Int J Oncol 19:71-81.
28. Korang K, Christiano AM, Uitto J, Mauviel A. 1995. Differential cytokine modulation of the genes LAMA3, LAMB3, and LAMC2, encoding the constitutive polypeptides, alpha 3, beta 3, and gamma 2, of human laminin 5 in epidermal keratinocytes. FEBS Lett 368:556-558.
29. Maehara Y, Kakeji Y, Kabashima A, Emi Y, Watanabe A, Akazawa K, Baba H, Kohnoe S, Sugimachi K. 1999. Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 17:607-614.
30. Malinda KM, Kleinman HK. 1996. The laminins. Int J Biochem Cell Biol 28:957-959.
31. Massagué J. 1990. The transforming growth factor-beta family. Annu Rev Cell Biol 6:597-641.
32. Massagué J. 1998. TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
33. Massagué J, Wotton D. 2000. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19:1745-1754.
34. Mulder KM, Morris SL. 1992. Activation of p21 ras by transforming growth factor beta in epithelial cells. J Biol Chem 267:5029-5031.
35. Oft M, Heider K-H, Beug H. 1998. TGFB signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8:1243-1252.
36. Okuda A, Kimura G. 1996. An amino acid change in novel protein D123 is responsible for temperature-sensitive G1-phase arrest in a mutant of rat fibroblast line 3Y1. Exp Cell Res 223:242-249.
37. Park B-J, Park J-I, Byun D-S, Park J-H, Chi S-G. 2000. Mitogenic conversion of transforming growth factor-B1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. Cancer Res 60:3031-3038.
38. Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA. 2001. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 3:708-714.
39. Piek E, Heldin C-H, Ten Dijke P. 1999. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 13:2105-2124.
40. Roberts AB, Sporn MB. 1990. The transforming growth factor-betas. In: Sporn MB, Roberts AB, editors. Handbook of Experimental Pharmacology. Heidelberg: Springer. p. 419-472.
41. Sanvito F, Herrera P-L, Huarte J, Nichols A, Montesano R, Orci L, Vassalli J-D. 1994. TGF-beta1 influences the relative development of the exocrine and endocrine pancreas in vitro. Development 120:3451-3462.
42. Satterwhite DJ, Aakre ME, Gorska AE, Moses HL. 1994. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells. Cell Growth Differ 5:789-799.
43. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K. 1996. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 272:1179-1182.
44. Stacey DW, Hitomi M, Kanovsky M, Gan L, Johnson EM. 1999. Cell cycle arrest and morphological alterations following microinjection of NIH3T3 cells with pur alpha. Oncogene 22:4254-4261.
45. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC. 1995. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res 23:4907-4912.
46. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL, Rowley DA. 1990. A highly immunogenic tumor transfected with a murine transforming growth factor type beta1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 87:1486-1490.
47. Walker J, Rigley K. 2000. Gene expression profiling in human blood mononuclear cells using high-density filter-based cDNA microarrays. J Immunol Methods 239:167-179.
48. Wang W, Zhou G, Hu MC-T, Yao Z, Tan T-H. 1997. Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction. J Biol Chem 272:22771-22775.
49. Webb CP, Van Aelst L, Wigler MH, Vande Woude GF. 1998. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci USA 95:8773-8778.
50. Xu X, Brodie SG, Yang X, Im Y-H, Parks WT, Chen L, Zhou Y-X, Weinstein M, Kim S-J, Deng C-X. 2000. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19:1868-1874.
51. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. 1995. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270:2008-2011.
52. Zavadil J, Bitzer M, Liang D, Yang Y-C, Massimi A, Kneitz S, Piek E, Böttinger EP. 2001. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci USA 98:6686-6691.